Literature DB >> 17665987

The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapy.

Sonia C Picinich1, Pravin J Mishra, Prasun J Mishra, John Glod, Debabrata Banerjee.   

Abstract

Mesenchymal stem cells (MSCs) are multipotent cells with a number of potential therapeutic applications. At present, they are being used in a clinical trial for the treatment of myocardial infarction and are being studied as a therapy for other vascular disorders. Treatments of neurologic disorders and anticancer therapy with MSCs have progressed in light of the migratory properties of MSCs to brain injury and tumors. The osteogenic potential of MSCs is being exploited in work investigating their use in bone regeneration therapy, and the immunomodulatory function of MSCs is being evaluated as a possible therapy for graft-versus-host disease. Here, the authors review recent work contributing to the knowledge of MSC biology and the advances in gene therapy and tissue regeneration using MSCs.

Entities:  

Mesh:

Year:  2007        PMID: 17665987     DOI: 10.1517/14712598.7.7.965

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  41 in total

Review 1.  Stem cells as therapeutic vehicles for the treatment of high-grade gliomas.

Authors:  Emanuela Binello; Isabelle M Germano
Journal:  Neuro Oncol       Date:  2011-12-13       Impact factor: 12.300

Review 2.  Mesenchymal stem cell-based tumor-targeted gene therapy in gastrointestinal cancer.

Authors:  Qi Bao; Yue Zhao; Hanno Niess; Claudius Conrad; Bettina Schwarz; Karl-Walter Jauch; Ralf Huss; Peter J Nelson; Christiane J Bruns
Journal:  Stem Cells Dev       Date:  2012-06-26       Impact factor: 3.272

Review 3.  Biomaterial technology for tissue engineering applications.

Authors:  Yasuhiko Tabata
Journal:  J R Soc Interface       Date:  2009-03-04       Impact factor: 4.118

4.  Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS.

Authors:  Masatoshi Suzuki; Jacalyn McHugh; Craig Tork; Brandon Shelley; Antonio Hayes; Ilaria Bellantuono; Patrick Aebischer; Clive N Svendsen
Journal:  Mol Ther       Date:  2008-09-16       Impact factor: 11.454

5.  Mesenchymal stem cells: revisiting history, concepts, and assays.

Authors:  Paolo Bianco; Pamela Gehron Robey; Paul J Simmons
Journal:  Cell Stem Cell       Date:  2008-04-10       Impact factor: 24.633

6.  Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model.

Authors:  Juha P Laurila; Lilja Laatikainen; Maria D Castellone; Parul Trivedi; Jari Heikkila; Ari Hinkkanen; Peiman Hematti; Mikko O Laukkanen
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

7.  Formation of bone-like mineralized matrix by periodontal ligament cells in vivo: a morphological study in rats.

Authors:  Toru Hiraga; Tadashi Ninomiya; Akihiro Hosoya; Masafumi Takahashi; Hiroaki Nakamura
Journal:  J Bone Miner Metab       Date:  2009-02-13       Impact factor: 2.626

8.  Tumor cell behaviour modulation by mesenchymal stromal cells.

Authors:  Lucia Kucerova; Miroslava Matuskova; Kristina Hlubinova; Veronika Altanerova; Cestmir Altaner
Journal:  Mol Cancer       Date:  2010-05-28       Impact factor: 27.401

9.  A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.

Authors:  Ruth S Waterman; Suzanne L Tomchuck; Sarah L Henkle; Aline M Betancourt
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

10.  Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells.

Authors:  Amber Wilson; Lina A Shehadeh; Hong Yu; Keith A Webster
Journal:  BMC Genomics       Date:  2010-04-07       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.